retatrutide values are from the published Phase 2 work and may be refined as Phase 3 data accumulates
Conclusion Exploring the link between GLP-1 medications and mental health shows we need more research
Future Directions in Incretin Therapy The success of oral semaglutide has sparked interest in additional oral incretin therapies and combination drugs
It gives us pause to say for an average employer group out there if youre investing in this medication for your employees, dont expect to see a return in year one. According to Joseph Leach, M.D., Senior Vice President and Chief Medical Officer at Prime, We will need results of ongoing, multi-year studies to see if this treatment has downstream impacts on other health conditions, including cardiovascular events and diabetes development prevention, which are key benefits to weight loss management
Weve had Ozempic Face, Ozempic Butt, and now, its Ozempic Vulva